Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
JH

Jonathan Houze — 56 Patents

AMAmgen: 45 patents #11 of 2,867Top 1%
TLTularik Limited: 11 patents #7 of 142Top 5%
VNVigil Neuroscience: 7 patents #1 of 13Top 8%
JTJapan Tobacco: 3 patents #223 of 1,187Top 20%
Cambridge, MA: #109 of 8,183 inventorsTop 2%
Massachusetts: #952 of 88,656 inventorsTop 2%
Overall (All Time): #44,020 of 4,157,543Top 2%
56 Patents All Time
Jonathan Houze has been granted 56 US patents while listed as an inventor at Amgen. The first was granted in 2001 and the most recent in September 2025. Jonathan Houze ranks #44,020 of 4,157,543 US inventors in our database (top 1.1%). Patent records list Jonathan Houze in Cambridge, MA, US.

Issued Patents All Time

Showing 1–25 of 56 patents

Patent #TitleCo-InventorsDateApprox Value ⓘ
12428425 Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agonists and methods of use Lara C. Czabaniuk, Timothy Hopper, Jane Panteleev, Gwenaella Rescourio, Vincent Santora +7 more 2025-09-30
12319691 Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agonists and methods of use Lara C. Czabaniuk, Timothy Hopper, Gwenaella Rescourio, Vincent Santora, Haoxuan Wang +3 more 2025-06-03
12252489 Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agonists and methods of use Lara C. Czabaniuk, Timothy Hopper, Gwenaella Rescourio, Vincent Santora, Haoxuan Wang +3 more 2025-03-18
11912711 Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agonists and methods of use Lara C. Czabaniuk, Timothy Hopper, Jane Panteleev, Gwenaella Rescourio, Vincent Santora +7 more 2024-02-27 $716,893,000
11884675 Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agonists and methods of use Lara C. Czabaniuk, Timothy Hopper, Jane Panteleev, Gwenaella Rescourio, Vincent Santora +7 more 2024-01-30 $465,532,000
11718617 Heterocyclic compounds as triggering receptor expressed on myeloid cells2 agonists and methods of use Lara C. Czabaniuk, Timothy Hopper, Gwenaella Rescourio, Vincent Santora, Haoxuan Wang +3 more 2023-08-08 $855,538,000
11608344 Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agonists and methods of use Lara C. Czabaniuk, Timothy Hopper, Jane Panteleev, Gwenaella Rescourio, Vincent Santora +7 more 2023-03-21 $375,298,000
11306107 Compounds that inhibit MCL-1 protein Sean P. Brown, David Karl Bedke, Michael R. DeGraffenreid, Jiasheng Fu, Zhihong Li +23 more 2022-04-19 $184,680,000
11191762 Alkyl substituted triazole compounds as agonists of the APJ Receptor Yinhong Chen, Mikkel V. Debenedetto, Paul John Dransfield, James S. Harvey, Aarif Yusuf Khakoo +8 more 2021-12-07 $140,935,000
11046680 Heteroaryl-substituted triazoles as APJ receptor agonists Ning Chen, Xiaoqi Chen, Yinhong Chen, Alan C. Cheng, Richard V. Connors +24 more 2021-06-29 $263,699,000
11020395 Cycloalkyl substituted triazole compounds as agonists of the APJ receptor Yinhong Chen, Paul John Dransfield, James S. Harvey, Julie Anne Heath, Aarif Yusuf Khakoo +8 more 2021-06-01 $258,451,000
10906890 Triazole phenyl compounds as agonists of the APJ receptor Ning Chen, Yinhong Chen, Mikkel V. Debenedetto, Paul John Dransfield, James S. Harvey +9 more 2021-02-02 $295,872,000
10736883 Triazole furan compounds as agonists of the APJ receptor Matthew Brown, Ning Chen, Xiaoqi Chen, Yinhong Chen, Alan C. Cheng +21 more 2020-08-11 $456,204,000
10689367 Triazole pyridyl compounds as agonists of the APJ receptor Yinhong Chen, Alan C. Cheng, Mikkel V. Debenedetto, Paul John Dransfield, James S. Harvey +8 more 2020-06-23 $918,346,000
10221162 Triazole agonists of the APJ receptor Ning Chen, Xiaoqi Chen, Yinhong Chen, Alan C. Cheng, Richard V. Connors +26 more 2019-03-05 $223,767,000
10150760 Compounds for use in preparing heterocyclic triazole agonists of the APJ receptor Xiaoqi Chen, Alan C. Cheng, Richard V. Connors, Mikkel V. Debenedetto, Paul John Dransfield +11 more 2018-12-11 $516,303,000
9988369 Heterocyclic triazole compounds as agonists of the APJ receptor Xiaoqi Chen, Yinhong Chen, Alan C. Cheng, Richard V. Connors, Mikkel V. Debenedetto +16 more 2018-06-05 $105,748,000
9868721 Triazole agonists of the APJ receptor Ning Chen, Xiaoqi Chen, Yinhong Chen, Alan C. Cheng, Richard V. Connors +26 more 2018-01-16 $517,957,000
9845310 Intermediates for preparing triazole agonists of the APJ receptor Ning Chen, Xiaoqi Chen, Alan C. Cheng, Richard V. Connors, Jeffrey Deignan +19 more 2017-12-19 $492,394,000
9751864 Methods for preparing triazole agonists of the APJ receptor Ning Chen, Xiaoqi Chen, Richard V. Connors, Jeffrey Deignan, Paul John Dransfield +20 more 2017-09-05 $648,500,000
9745286 Triazole agonists of the APJ receptor Ning Chen, Xiaoqi Chen, Yinhong Chen, Alan C. Cheng, Richard V. Connors +26 more 2017-08-29 $315,817,000
9656998 Intermediates for preparing triazole agonists of the APJ receptor Ning Chen, Xiaoqi Chen, Richard V. Connors, Jeffrey Deignan, Paul John Dransfield +20 more 2017-05-23 $178,842,000
9656997 Triazole agonists of the APJ receptor Ning Chen, Xiaoqi Chen, Alan C. Cheng, Richard V. Connors, Jeffrey Deignan +23 more 2017-05-23 $178,842,000
9573936 Triazole agonists of the APJ receptor Ning Chen, Xiaoqi Chen, Yinhong Chen, Alan C. Cheng, Richard V. Connors +26 more 2017-02-21 $201,004,000
8785468 Phenylalanine amide derivatives useful for treating insulin-related diseases and conditions Xiaohui Du, Zice Fu, XianYun Jiao, Yong-Jae Kim, Leping Li +6 more 2014-07-22 $478,714,000